Sunstone Hotel Investors' common and preferred stocks have lost significant market value, presenting a potential buying opportunity despite macroeconomic headwinds. Sunstone's preferred shares ...

Viking soared more than 100% in one trading session last year on positive clinical trial news. The stock has since given up those gains, but its weight loss drug program continues to advance and ...

Viking Therapeutics (NASDAQ: VKTX) is operating in one of the highest-growth pharma areas around. I'm talking about the weight loss drug market -- one that Morgan Stanley analysts say may multiply ...

The easiest way to reach Sunstone Island in Fisch is to head northeast from Moosewood, found close to the Statue of Sovereignty. This area can be found at the coordinates (X: -932, Y: 131 ...

In somewhat of a surprise move, Viking Therapeutics just announced a production deal with CordenPharma, a privately held Swiss company. The move supports the commercial launch of a drug just now ...

In the latest quarter, 4 analysts provided ratings for Sunstone Hotel Invts SHO, showcasing a mix of bullish and bearish perspectives. The table below provides a snapshot of their recent ratings ...

We recently published a list of 10 Stocks Skyrocketing Today. In this article, we are going to take a look at where Viking Therapeutics Inc. (NASDAQ:VKTX) stands against other stocks that are ...

Viking isn't generating consistent revenue today but it could have a blockbuster drug on its hands in VK2735. The weight loss candidate begins phase 3 trials this year, and positive results could ...

Viking Therapeutics (NASDAQ: VKTX) is a promising growth stock with a strong GLP-1 drug candidate in VK2735, which may eventually rake in significant revenue from the anti-obesity market.